[HTML][HTML] Metabolomics and systems pharmacology: why and how to model the human metabolic network for drug discovery

DB Kell, R Goodacre - Drug Discovery Today, 2014 - Elsevier
Highlights•We now have metabolic network models; the metabolome is represented by their
nodes.•Metabolite levels are sensitive to changes in enzyme activities.•Drugs hitchhike on …

Pharmacotherapy of acute lung injury and acute respiratory distress syndrome

K Raghavendran, GS Pryhuber… - Current medicinal …, 2008 - ingentaconnect.com
Acute lung injury (ALI) and the acute respiratory distress syndrome (ARDS) are
characterized by rapid-onset respiratory failure following a variety of direct and indirect …

Icariin, a phoshphodiesterase-5 inhibitor, improves learning and memory in APP/PS1 transgenic mice by stimulation of NO/cGMP signalling

F Jin, QH Gong, YS Xu, LN Wang, H Jin… - International Journal …, 2014 - academic.oup.com
Abstract Phosphodiesterase-5 (PDE5) inhibitors are predominantly used in the treatment of
erectile dysfunction, and have been recently shown to have a potential therapeutic effect for …

[HTML][HTML] AlzPathway: a comprehensive map of signaling pathways of Alzheimer's disease

S Mizuno, R Iijima, S Ogishima, M Kikuchi… - BMC systems …, 2012 - Springer
Background Alzheimer's disease (AD) is the most common cause of dementia among the
elderly. To clarify pathogenesis of AD, thousands of reports have been accumulating …

Therapeutic potential of phosphodiesterase inhibitors against neurodegeneration: The perspective of the medicinal chemist

G Ribaudo, A Ongaro, G Zagotto, M Memo… - ACS chemical …, 2020 - ACS Publications
Increasing human life expectancy prompts the development of novel remedies for cognitive
decline: 44 million people worldwide are affected by dementia, and this number is predicted …

Phosphodiesterases in the central nervous system: implications in mood and cognitive disorders

Y Xu, HT Zhang, JM O'Donnell - Phosphodiesterases as drug targets, 2011 - Springer
Cyclic nucleotide phosphodiesterases (PDEs) are a superfamily of enzymes that are
involved in the regulation of the intracellular second messengers cyclic AMP (cAMP) and …

[HTML][HTML] Cigarette smoking impairs nitric oxide-mediated cerebral blood flow increase: Implications for Alzheimer's disease

N Toda, T Okamura - Journal of pharmacological sciences, 2016 - Elsevier
Cerebral blood flow is mainly regulated by nitrergic (parasympathetic, postganglionic)
nerves and nitric oxide (NO) liberated from endothelial cells in response to shear stress and …

Hepatoprotective effects of diosmin and/or sildenafil against cholestatic liver cirrhosis: The role of Keap-1/Nrf-2 and P38-MAPK/NF-κB/iNOS signaling pathway

FEM Ali, AA Azouz, AG Bakr, AM Abo-Youssef… - Food and Chemical …, 2018 - Elsevier
The present study was designed to investigate the potential protective effects of diosmin
(DS) and/or sildenafil against bile duct ligation (BDL). In order to achieve this goal, BDL was …

Neuroprotective mechanisms of sildenafil and selenium in PTZ-kindling model: implications in epilepsy

KM Tawfik, YM Moustafa, MF El-Azab - European Journal of Pharmacology, 2018 - Elsevier
Epilepsy is one of the furthermost common neurodegenerative diseases affecting above 50
million individuals worldwide. The pathogenesis of epileptic seizures is not satisfactorily …

Role of phosphodiesterase 5 in synaptic plasticity and memory

D Puzzo, S Sapienza, O Arancio… - … disease and treatment, 2008 - Taylor & Francis
Phosphodiesterases (PDEs) are enzymes that break down the phosphodiesteric bond of the
cyclic nucleotides, cAMP and cGMP, second messengers that regulate many biological …